Molecular docking, MD simulation, and anticancer evaluation of 2-amino-4H-chromenes via green synthesis
Authors: Shekdar, Vishvakarma R; Jadhav, Shravan Y; Bavi, Rohit S; Chaugule, Hanmant N; Bhadange, Nagesh V; Kore, Dayanand C; Kadampalle, Umakant M; Makane, Vitthal B; Zaki, Magdi E A; Masand, Vijay H
Source journal: Biochemical and biophysical research communications (2026-11-12)
DOI: 10.1016/j.bbrc.2026.154884
Abstract
The discovery of structurally diverse anticancer agents through sustainable synthetic methodologies remains a central challenge in contemporary medicinal chemistry. In the present study, we report a green and efficient one-pot multicomponent synthesis of a series of novel 4H-chromene derivatives (4a-j) using the ionic liquid triethylammonium hydrogen sulfate [Et(3)NH][HSO(4)] as a recyclable catalyst and reaction medium. The protocol afforded the desired chromene derivatives in excellent yields under mild reaction conditions with reduced reaction times, demonstrating an environmentally benign alternative to conventional synthetic approaches. The synthesized compounds were fully characterized by spectroscopic techniques and evaluated for their in vitro antiproliferative activity against MCF-7 (breast adenocarcinoma), HepG-2 (hepatocellular carcinoma), and HCT-116 (colorectal carcinoma) cell lines. Structure-activity relationship analysis revealed that compounds 4g and 4i were the most active derivatives. Compound 4g exhibited the highest cytotoxicity against MCF-7 cells (IC(50) = 2.25 muM), whereas compound 4i demonstrated superior activity against HepG-2 (IC(50) = 2.61 muM) and HCT-116 (IC(50) = 2.48 muM) cells, with antiproliferative potency approaching that of the reference drug doxorubicin. To elucidate the molecular mechanism underlying their biological activity, the lead compounds were investigated using an integrated computer-aided drug design workflow comprising molecular docking, molecular dynamics simulations, MM/GBSA binding free energy calculations, and ADMET prediction. Docking studies identified compound 4g as the most favorable tubulin binder (Gold Fitness Score = 51.41), establishing key hydrogen-bonding interactions with Ser 132 and Gln15, together with pi-pi stacking interactions involving Tyr210. Subsequent 100 ns molecular dynamics simulations confirmed the conformational stability of the protein-ligand complexes, while MM/GBSA calculations demonstrated that the 5NM5-4 g complex possessed the most favorable binding free energy (-403.22 +/- 13.83 kcal mol(-1)), predominantly driven by van der Waals, lipophilic, electrostatic, and hydrogen-bonding interactions. Furthermore, in silico ADMET analysis predicted favorable drug-likeness and pharmacokinetic characteristics for the lead compounds. Collectively, the excellent agreement between the experimental and computational investigations identifies compound 4g, followed by compound 4i, as promising tubulin-targeted lead molecules for further optimization toward the development of next-generation anticancer therapeutics.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.